Influenza virus neuraminidase activates latent transforming growth factor β

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8624-8629

  Schultz Cherry, Stacey ^a   Hinshaw, Virginia S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; ENZYME ANALYSIS; ENZYME MECHANISM; GROWTH REGULATION; IMMUNE RESPONSE; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0029861191     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8624-8629.1996     Document Type: Article

References (27)

1. Carding, S. R., W. Allan, A. McMickle, and P. C. Doherty. 1993. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J. Exp. Med. 177:475-482.
2. Hinshaw, V. S., C. W. Olsen, N. Dybdahl-Sissoko, and D. Evans. 1994. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68:3667-3673.
3. Kim, S. J., J. H. Kehrl, J. Burton, C. L. Tendler, K. T. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, M. B. Sporn, and A. B. Roberts. 1990. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J. Exp. Med. 172:121-129.
4. Klasing, K. C. 1994. Avian leukocytic cytokines. Poult. Sci. 73:1035-1043.
5. Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1204. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology. Lippincolt-Raven, Philadelphia.
6. Lamb, R. A., and R. M. Krug. 1996. Orthomyxoviridae: the viruses and their replication, p. 1353-1397. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology. Lippincott-Raven, Philadelphia.
7. Liu, C., M. C. Eichelberger, R. W. Compans, and G. M. Air. 1995. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1009-1106.
8. Lomo, J., H. K. Blomhoff, K. Beiske, T. A. Stokke, and E. B. Smeland. 1995. TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 154:1635-1643.
9. Massague, J., S. Cheifetz, M. Laiho, D. A. Ralph, F. M. B. Weiss, and A. Zentella. 1992. Transforming growth factor-β. Cancer Surv. 12:81-102.
10. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukocyte Biol. 55:401-409.
11. Michelson, S., J. Alcami, S. J. Kim, D. Danielpour, F. Bachelerie, L. Picard, C. Bessia, C. Paya, and J. L. Virelizier. 1994. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J. Virol. 68:5730-5737.
12. Miyazono, K., and C. Heldin. 1989. Role for Carbohydrate Structures in TGF-β1 latency. Nature (London) 338:158-160.
13. Palese, P., and R. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
14. Peschke, T., A. Bender, M. Nain, and D. Gemsa. 1993. Role of macrophage cylokincs in influenza A virus infections, Immunobiology 189:340-355.
15. Philpott, M., B. C. Easterday, and V. S. Hinshaw. 1989. Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity. J. Virol. 63:3453-3458.
16. Quinlan, M. P. 1993. E1A 12S in the absence of E1B or other cooperating oncogenes enables cells to overcome apoptosis. Oncogene 8:3289-3296.
17. Rifkin, D. B., S. Kojima, M. Abe, and J. G. Harpel. 1993. TGF-β: structure, function, and formation. Thromb. Haemostasis 70:177-179.
18. Ronni, T., T. Sareneva, J. Pirhonen, and I. Julkunen. 1995. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclcar cells. J. Immunol. 154:2764-2774.
19. Schulman, J. L., M. Khakpour, and E. D. Kilbourne. 1968. Protective effects of specific immunity to viral neuraminidase on influenza infection of mice. J. Virol. 2:778-786.
20. Schultz-Cherry, S., H. Chen, D. F. Mosher, T. M. Misenheimer, H. C. Krutzsch, D. D. Roberts, and J. E. Murphy-Ullrich. 1995. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270:7304-7310.
21. Schultz-Cherry, S., J. Lawler, and J. E. Murphy-Ullrich. 1994. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J. Biol. Chem. 269:26783-26788.
22. Schultz-Cherry, S., and J. E. Murphy-Ullrich. 1993. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:923-932.
23. Schultz-Cherry, S., S. Ribeiro, L. Gentry, and J. E. Murphy-Ullrich. 1994. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically-defined system. J. Biol. Chem. 269:26775-26782.
24. Van Campen, H., B. C. Easterday, and V. S. Hinshaw. 1989. Destruction of lymphocytes by a virulent avian influenza A virus. J. Gen. Virol. 70:467-472.
25. Van Campen, H., B. C. Easterday, and V. S. Hinshaw. 1989. Virulent avian influenza A viruses: their effect on avian lymphocytes and macrophages in vivo and in vitro. J. Gen. Virol. 70:2887-2895.
26. Wahl, S. M. 1992. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 12:61-74.
27. Webster, R. G., P. A. Reay, and W. G. Laver. 1988. Protection against lethal influenza with neuraminidase. Virology 164:230-237.